NI
Nika Pharmaceuticals Inc.
NIKA · OTC
$0.41 +0.00% (+$0.00)
Market Cap $429.9M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.29
29.3% downside
Current Price
$0.41
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NIKA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 23.63%
Asset turnover 0.00x
ROA 785.81%
Debt
0 /100
High Current ratio 0.03x
Debt/Equity N/A
Debt/Assets N/A
Stability
32 /100
Unstable Beta -2.48x
Profitable years 0
EPS volatility 56.13%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NIKA
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dimitar Slavchev Savov
Employees
0
Headquarters
Henderson